Mu-conotoxin CAS:936616-33-0

Mu-conotoxin has garnered attention for its potential pharmaceutical applications, particularly in pain management and neurological disorders. By selectively blocking specific types of voltage-gated sodium channels, Mu-conotoxin offers a targeted approach to pain relief without the side effects associated with traditional analgesics. This toxin's ability to modulate neuronal excitability also holds promise for treating conditions like epilepsy and neuropathic pain. Research into Mu-conotoxin variants continues to explore their therapeutic efficacy and safety, paving the way for novel treatments in clinical medicine.